Application
Western blot analysis of EOMES (arrow) using rabbit polyclonal EOMES Antibody (Human N-term) (RB10349).293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the EOMES gene (Lane 2) (Origene Technologies).| Product Name | EOMES (TBR2) Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | EOMES; TBR2; Eomesodermin homolog; T-box brain protein 2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:50~100 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | TBR2 |
|---|---|
| Alternative Names | EOMES TBR2 Eomesodermin homolog T-box brain protein 2 |
| Molecular Weight(MW) | 72732 Da |
| Function | Functions as a transcriptional activator playing a crucial role during development. Functions in trophoblast differentiation and later in gastrulation, regulating both mesoderm delamination and endoderm specification. Plays a role in brain development being required for the specification and the proliferation of the intermediate progenitor cells and their progeny in the cerebral cortex. Also involved in the differentiation of CD8+ T-cells during immune response regulating the expression of lytic effector genes |
| Tissue Specificity | Expressed in CD8+ T-cells. |
| Cellular Localization | Nucleus (Probable). |
| Entrez Gene | 8320 |
|---|
Application
Western blot analysis of EOMES (arrow) using rabbit polyclonal EOMES Antibody (Human N-term) (RB10349).293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the EOMES gene (Lane 2) (Origene Technologies).| Application Notes | WB:1:50~100 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
